Tocilizumab Prefilled Syringe

DRUG3 trials

Sponsors

Lille Catholic University, Karolinska University Hospital, Syneos Health

Conditions

Arthritis, RheumatoidCovid-19Giant Cell ArteritisRheumatoid Arthritis

Phase 1

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

CompletedNCT04885829

Syneos HealthGiant Cell Arteritis, Rheumatoid Arthritis

Start: 2021-05-31End: 2023-05-04Updated: 2024-01-05

Phase 2

A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study

Karolinska University HospitalCovid-19

Start: 2020-06-11End: 2021-06-30Target: 120Updated: 2021-02-18

Phase 4

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Lille Catholic UniversityArthritis, Rheumatoid

Start: 2018-01-22End: 2024-11-30Target: 224Updated: 2023-09-13

Related Papers

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial

BMJ Open2025-06-01

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial

PLoS ONE2023-12-298 citations